Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Twist Bioscience Corporation

< Previous 1 2 3 4 5 6 Next >
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Addresses Misleading Short-Seller Report
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Human Sample ID Kit to Track Whole Blood Samples Through Lab Testing Workflow
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Earns 2022 Great Place to Work Certification
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at JSNN NanoImpacts 2022
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Baird 2022 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Flash Memory Summit
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Second Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches High Throughput Antibody Production Platform
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Become Voting Member of Storage Networking Industry Association
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.